Mandate

Vinge advises Expedition Growth Capital in connection with Storykit’s USD 10 million investment round

Vinge advises Expedition Growth Capital in connection with Storykit’s investment round of USD 10 million led by Expedition Growth Capital. The investment in Storykit is Expedition Growth Capital’s first investment in the Nordics.

Serving large and medium sized enterprises, Storykit is leveraging artificial intelligence enabling its users to create video and tell stories on social platforms, and has quickly grown to become the leading video creator in the Nordics as well as recently expanded into several European markets. With the new funding, they will accelerate innovation and expansion at an even higher pace.

Expedition Growth Capital is a USD 200+ million London-based growth equity fund, focused solely on investing in fast growing and capital efficient B2B software companies in Europe and Israel, and this is Expedition Growth Capital’s first investment in the Nordics.

Vinge’s team consisted of Karl Klackenberg, Johan Larsson, Milad Kamali and Nina Gransäter (M&A), Stojan Arnerstål (IPR), Lisa Hörnqvist (Commercial Agreements) and Veronika Garemark (Employment).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025